Gabather AB (publ) (STO:GABA)
Sweden · Delayed Price · Currency is SEK 0.0528
+0.0060 (12.82%)
At close: Mar 27, 2026
Gabather AB Market Cap
Gabather AB has a market cap or net worth of 25.96 million as of March 27, 2026. Its market cap has increased by 1,363.67% in one year.
Market Cap
25.96M
Enterprise Value
22.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since November 3, 2014, Gabather AB's market cap has decreased from 43.24M to 25.96M, a decrease of -39.97%. That is a compound annual growth rate of -4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 25.96M | 131.39% |
| Dec 30, 2025 | 11.22M | 18.25% |
| Dec 30, 2024 | 9.49M | -54.20% |
| Dec 29, 2023 | 20.71M | -66.45% |
| Dec 30, 2022 | 61.73M | 1.64% |
| Dec 30, 2021 | 60.74M | -19.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.57B |
| Dicot Pharma AB | 835.89M |
| Orexo AB | 788.60M |
| Cinclus Pharma Holding AB | 779.04M |
| Nanexa AB | 597.44M |
| Enzymatica AB | 580.14M |
| Moberg Pharma AB | 467.66M |
| Klaria Pharma Holding AB (publ.) | 196.29M |